Contrast-enhanced mammography-guided biopsy: technique and initial outcomes

Contrast-enhanced mammography-guided biopsy (CEM-Bx), a novel technique for diagnosing suspicious enhanced lesions, was commercialized for clinical application in 2021; however, there are only a few publications documenting this technique in the existing literature. The aim of this study was to eval...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Ya-Chun, Cheung, Yun-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423379/
https://www.ncbi.nlm.nih.gov/pubmed/37581028
http://dx.doi.org/10.21037/qims-23-137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423379/
https://www.ncbi.nlm.nih.gov/pubmed/37581028
http://dx.doi.org/10.21037/qims-23-137

Ejemplares similares